Catechins can reduce secondary inflammation in rats by inhibiting the production of IL-1, TNF-α, and PGE2 in an adjuvant-induced arthritis model and by upregulating the expression of EP2 in rat synovial cells [32]. The gene discussed is IL1B; the disease is arthritic joint disease.